FOR AUTHORS
Search
Search Results
##search.searchResults.foundPlural##
-
PO097 | DETERMINANTS OF PLATELET COUNT IN A LARGE SINGLE TERTIARY CARE COHORT: IMPACT OF AGE, SEX, PLATELET REACTIVITY, CARDIOVASCULAR RISK FACTORS AND ANTIPLATELET THERAPY S. De Corci, N. Manganello, E. Schiera, S. Terracina, A. Di Battista, F.M. Pulcinelli | Experimental Medicine, Sapienza University of Rome, Italy
60PDF: 21 -
PO55 | HISTORY OF CANCER IN PATIENTS WITH SEVERE HEREDITARY THROMBOPHILIA VERSUS NO THROMBOPHILIA: A SINGLE-CENTER COHORT OF PATIENTS WITH VENOUS THROMBOSIS A. Napolitano, E. Campello, C. Simion, G. Furlan, S. Gavasso, C. Bulato, C. Samà, S. Toffanin, B. Serena, L. Spiezia, P. Simioni | Internal Medicine 1 and Thrombotic and Hemorrhagic Diseases Unit, Department of Medicine, University of Padova, Italy
533PDF: 115 -
PO41 | Comparison of the haemorrhagic phenotype between female and male patients affected by autosomal inherited bleeding disorders in a single-centre cohort B. Borsellino1,3, C. Zuccotti2, L. Guarnera3,4, C. Biasoli5, P. Pedrazzi5, T. Martini1 | 1Haemophilia Centre, Immune-Haematology and Transfusion Medicine, University Hospital “Città della Salute e della Scienza”, Turin, Italy; 2Department of Clinical Pathology, Bufalini Hospital, Cesena, Italy; 3Department of Biomedicine and Prevention, PhD in Immunology, Molecular Medicine and Applied Biotechnology, University of Roma Tor Vergata, Roma, Italy; 4Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA; 5Haemophilia and Transfusion Centre, Bufalini Hospital, Cesena, Italy
630PDF: 31 -
PO004 | SEX-RELATED DIFFERENCES AND PREDICTORS OF MORTALITY IN MAJOR ORTHOPEDIC SURGERY: INSIGHTS FROM THE ORTHO-START REGISTRY A. de Laurenzo1, E. Antonucci2, C. Rostagno3, D. Barcellona4, D. Colaizzo1, G. di Rienzo5, F. Gorgoglione1, G. Maccagnano6, F. Marongiu2, M. Mastroianno1, M. Marzolo7, L. Mirabella6, B. Moretti8, A.M. Moretti9, A. Ostuni6, G. Palareti2, M. Margaglione6, E. Grandone1|6 | 1Fondazione I.R.C.C.S. “Casa Sollievo della Sofferenza”, S. Giovanni R. (Foggia), Italy; 2Fondazione Arianna, Bologna, Italy; 3Department of Internal and Postoperative Medicine, Careggi University Hospital, Firenze, Italy; 4Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy; 5UOC Patologia Clinica-Ospedale Altamura ASL Bari, Italy; 6University of Foggia, Policlinico Riuniti Foggia, Italy; 7Angiology Unit, Ospedale di Rovigo, Rovigo, Italy; 8School of Medicine, AOU Consorziale Policlinico, University of Bari "Aldo Moro", Italy; 9President of GISeG (Italian Group for Health and Gender), Bari, Italy
47PDF: 23 -
CO023 | STILL FAR FROM TARGET: REAL-WORLD LDL-CHOLESTEROL CONTROL, THERAPY USE, AND SEX DIFFERENCES IN TUSCANY L. Cosco1, M. Berteotti1, F. Alfano1, F. Profili2, B. Nreu3, G. Casolo4, A. Zuppiroli5, E. Mannucci3, P. Francesconi2, R. Marcucci1 | 1Department of Experimental and Clinical Medicine, University of Florence, Firenze, Italy; 2Epidemiology Unit, Regional Health Agency of Tuscany, Firenze, Italy; 3Diabetology Unit, Careggi University Hospital, Firenze, Italy; 4Cardiology Unit, Versilia Hospital, Lido di Camaiore, Italy; 5Former Department of Cardiology, Azienda Sanitaria di Firenze, Firenze, Italy
73PDF: 25 -
PO18 | Does muscle mass matter? Appendicular lean mass as a determinant of anti-XA activity in elderly patientes B.M. Zanforlini1, V. Bernardi1, E. Campello2, E.M. Bicego1, C. Curreri1, A. Vaticano1, C. Sartori1, L. Manfron1, A. Perencin1, P. Rollo1, A. Baruffol1, L. Ruoso1, C. Simion2, C. Bulato2, P. Berto2, P. Simioni2, G. Sergi1 | 1Department of Medicine, Geriatrics Section, University of Padova; 2Haemorrhagic and Thrombotic Diseases Unit, Department of Medicine DIMED, Padova University Hospital, Padova, Italy
611PDF: 21 -
CO51 | Novel biomarkers of neurological damage in acute immune-mediated thrombotic thrombocytopenic purpura A. Truma1,2, I. Mancini1, F. Verde2,3, J. A. Giannotta1, A. Artoni1, B. Ferrari1, P. Agosti1,2, M. Gagliardi1, A. Ratti3,4, N. Ticozzi2,3, F. Peyvandi1,2 | 1Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Milan; 2Università degli Studi di Milano, Department of Pathophysiology and Transplantation, Milan; 3Department of Neurology and Laboratory of Neuroscience, IRCCS Istituto Auxologico Italiano, Milan; 4Università degli Studi di Milano, Department of Medical Biotechnology and Translational Medicine, Milan, Italy
601PDF: 18 -
CO104 | PERIOPERATIVE BLEEDING IN CHILDREN WITH LOW VON WILLEBRAND FACTOR UNDERGOING ENT SURGERY: A 15-YEAR SINGLE-CENTER EXPERIENCE T. Martini1, B. Borsellino1, C. Linari2, U. Miglio2, B. Pollio1 | 1Hemophilia Centre, Immune-Hematology and Transfusion Medicine, University Hospital "Città della Salute e della Scienza", Torino, Italy; 2Laboratory Medicine, Regina Margherita Children's Hospital, 10126 Turin, Italy
52PDF: 29 -
PO008 | HISTORY OF CANCER IN VTE PATIENTS WITH AND WITHOUT HEREDITARY THROMBOPHILIA: A SINGLE CENTER COHORT STUDY A. Napolitano, E. Campello, C. Simion, G. Furlan, S. Gavasso, C. Bulato, C. Samà, S. Toffanin, B. Serena, L. Spiezia, P. Simioni | Department of Medicine, University of Padova, Italy
60PDF: 23 -
PO57 | A NOVEL RISK ASSESSMENT MODEL FOR CANCER DETECTION WITHIN ONE YEAR AFTER INCIDENT VENOUS THROMBOEMBOLISM C. Antoun1, J. Hansen1|3, S. Brækkan1|3, C. Langholm1, N. Eide1, V. Morelli1|3, K. Hveem2 | 1Department of Clinical Medicine, UiT The Arctic University of Norway, Tromsø; 2HUNT Center for Molecular and Clinical Epidemiology, Norwegian University of Science and Technology, Trondheim; 3Thrombosis Research Center, Division of Internal Medicine, University Hospital of North Norway, Tromsø, Norway
525PDF: 106 -
PO145 | KINETIC ASSESSMENT OF PLATELET REACTIVITY DURING DUAL ANTIPLATELET THERAPY IN ACUTE CORONARY SYNDROMES: PRELIMINARY RESULTS FROM AN ONGOING STUDY B. Di Marco1|2, R. Liani1, F. D’Ambrosio1|2, M. Alfonsetti1, P.G. Simeone1, M. Frezza1, S. Porro1, M. Brambilla3, P. Lanuti1, M. Camera3, F. Santilli1 | 1Department of Medicine and Aging Sciences, Center for Advanced Studies and Technology (CAST), University of Chieti, Chieti, Italy; 2ASL 2 Abruzzo, SS. Annunziata Hospital, Chieti, Italy; 3Unit of Cell and Molecular Biology in Cardiovascular Diseases, Centro Cardiologico Monzino IRCCS, Milano, Italy
58PDF: 21 -
PO52 | Comprehensive assessment of variables affecting spontaneous platelet aggregation C. Ghali1, A. Fioretti1, M. Scavone1, E. Bossi1, B. Clerici1, S. Birocchi1, E. Popov2, M. Centola3, G.M. Podda1, M. Cattaneo4 | 1Divisione di Medicina Generale II, ASST Santi Paolo e Carlo, DISS, Università degli Studi di Milano, Italy; 2National Medical Research Center of Cardiology, Ministry of Health of the Russian Federation, Moscow; 3Division of Cardiology, Pio XI Hospital, ASST Brianza, Desio, Italy; 4Fondazione Arianna Anticoagulazione, Bologna, Italy
691PDF: 29 -
PO143 | GENDER DIFFERENCES IN COAGULATION PROFILE IN OBSTRUCTIVE CORONARY ARTERY DISEASE: PRELIMINARY RESULTS FROM AN ANGIOGRAPHICALLY CONTROLLED COHORT STUDY N. Osti1, G. Musuraca1, M. Spizzo2, P. Pattini2, G. Mango2, F. Ambrosani2, G. Poli3, C. Brocco1, C. Angheben1, M. Donini1, F. Presa2, M. Grusse4, P. Van Dreden4, A. Anesi1, G. Lippi3, M. Del Greco1, A. Castagna2, S. Friso2, A. Ferro1, N. Martinelli2 | 1Azienda Sanitaria Universitaria Integrata del Trentino, Trento, Italy; 2Dip. di Medicina, Università di Verona, Verona, Italy; 3Sez. di Biochimica Clinica, Università di Verona, Verona, Italy; 4Clinical Research, Diagnostica STAGO, Gennevillers, France
56PDF: 27 -
CO067 | ELUCIDATING THE EVIL RELATIONSHIP OF METABOLIC DYSFUNCTION–ASSOCIATED FATTY LIVER DISEASE WITH CARDIOVASCULAR COMORBIDITIES: THE COMPLEX INTERPLAY AMONG HYPERCOAGULABILITY, INFLAMMATION, AND LIVER FIBROSIS G. Gagliardi, E. Campello, A. Napolitano, B. Stocco, C. Di Gesù, G. Gobbo, I. Condonato, M. Allegra, G. Antonello, C. Portinari, C. Goffi, G. Camporese, P. Scarinzi, R. Pesavento, F. Bilora, M. Di Pascoli, C. Bulato, A. Montagna, D. Regazzo, A. Zambon, L. Fabris, P. Simioni | Department of Medicine, University of Padova, Italy
67PDF: 25 -
CO048 | PREDICTORS OF FIRST THROMBOTIC EVENTS AFTER MECHANICAL VALVE REPLACEMENT FOR RHEUMATIC HEART DISEASE: A RETROSPECTIVE COHORT STUDY FROM SALAM CENTER FOR CARDIAC SURGERY (SUDAN) N. Erba1|3, S. Abdelwahab Abdallah1, D. Poli3, M. Langer2, G. Portella2, E. Giovanella1, F. Masini1, P. Malerba2 | 1The Salam Centre for Cardiac Surgery, Emergency NGO, Khartoum, Sudan; 2Emergency NGO Milano, Italy; 3Federazione dei Centri per la diagnosi della trombosi e la Sorveglianza delle terapie Anti trombotiche, Italy
71PDF: 25 -
CO19 | Hypercoagulability in wild-type transthyretin amyloidosis: evidence from whole blood thromboelastometry A. Napolitano1, L. Spiezia1, C. Samà1, A. Benetti1, G. Sinigiani2, L. De Michieli2, A. Cipriani2, P. Simioni1 | 1First Chair of Internal Medicine, Department of Medicine, University Hospital of Padua; 2Department of Cardiothoracic and Vascular Sciences & Public Health, University Hospital of Padua, Italy
610PDF: 19 -
CO007 | TPO-RECEPTOR AGONISTS AS AN INDEPENDENT RISK FACTOR FOR VENOUS THROMBOTIC EVENT IN IMMUNE THROMBOCYTOPENIA PATIENTS WITH PERSISTENT ANTIPHOSPHOLIPID ANTIBODIES POSITIVITY M. Biglietto, B. Mandelli, S. Sorella, S. Ligia, C. Andriola, R. Mormile, E. Baldacci, A. Chistolini, S. Truglia, C. Santoro | Sapienza, University of Rome, Italy
165PDF: 25 -
PO124 | BLEEDING COMPLICATIONS DURING ANTICOAGULATION WITH DOACS FOR NVAF AND THEIR MOST COMMON RISK FACTORS A. delle Femine, P. Di Micco, P. Sommese, M. Di Napoli, A. Di Salvatore, M. Galdiero, A. Lobasso, R. Serpico, V. Brunelli, A. Di Fusco, C. di Gennaro | U.O.C. Medicina Interna, Osp. Santa Maria delle Grazie, Pozzuoli, Italy
44PDF: 21 -
BEST-02 | PERIOPERATIVE BLEEDING IN CHILDREN WITH LOW VON WILLEBRAND FACTOR UNDERGOING ADENOID AND TONSIL SURGERY: A 15-YEAR SINGLE-CENTER EXPERIENCE T. Martini1, B. Borsellino1|2, B. Pollio1 | 1Haemophilia Centre, Immune-Haematology and Transfusion Medicine, University Hospital “Città della Salute e della Scienza”, Torino, Italy; 2Department of Biomedicine and Prevention, PhD in Immunology, Molecular Medicine and Applied Biotechnology, University of Rome Tor Vergata, Roma, Italy
168PDF: 28 -
Anticoagulation in obese patients: challenges and strategies
2047PDF: 542HTML: 310XML: 196 -
CO15 | Longitudinal coagulation profiling of individuals undergoing gender-affirming hormone therapy: the hyper-gender study A. Napolitano, E. Campello, A. Scala, C. Simion, C. Bulato, S. Gavasso, C. Samà, A. Benetti, S. Toffanin, G. Faggian, R. Scafa, A. Garolla, P. Simioni | First Chair of Internal Medicine, Department of Medicine, University Hospital of Padua; Unit of Andrology and Reproductive Medicine, Department of Medicine, University Hospital of Padua, Italy
691PDF: 23 -
CO071 | ATRIAL FIBRILLATION, CEREBRAL SMALL VESSEL DISEASE, AND GENDER MEDICINE: FOCUS ON BIOMARKERS AND NEUROIMAGING F. Alfano1|2, M. Berteotti1|2, F. Cesari1|2, AM. Gori1|2, E. Salvadori1, B. Giusti1|2, A. Bertelli1|2, L. Bicchi1|2, F. Fratini3, B. Formelli3, G. Salti3, E. Fainardi1|4, A. Ginestroni1|4, S. Chiti5, A. Poggesi1|3, R. Marcucci1|2 | 1Department of Experimental and Clinical Medicine, University of Florence, Firenze, Italy; 2Center for Atherothrombotic Diseases, Careggi University Hospital, Firenze, Italy; 3NEUROFARBA Department, Neuroscience Section, University of Florence, Firenze, Italy; 4Neuroradiology Unit, Careggi University Hospital, Firenze, Italy; 5Health Physics Unit, Careggi University Hospital, Firenze, Italy
72PDF: 36 -
PO58 | Gender differences in primary haemostasis A. Becchetti2, M. Brambilla2, M. Conti2, D. Trabattoni2, E. Tremoli3, M. Camera1,2 | 1Department of Pharmaceutical Sciences, Università degli Studi di Milano; 2Centro Cardiologico Monzino IRCCS, Milan; 3Maria Cecilia Hospital, Cotignola (RA), Italy
661PDF: 17 -
CO109 | THE ROLE OF SELECTED LDLR AND LRP1 VARIANTS IN MODULATING LDL AND FVIII LEVELS IN METABOLIC SYNDROME P. Agosti1|2, A. Cairo2, S. Spena2, S. Pelusi3, F. Malvestiti1, D. Prati3, M. Clerici2, E. Scalambrino2, A. Tripodi1|2, V. La Mura1|2, L. Valenti1|3, F. Peyvandi1|2 | 1Università degli Studi di Milano, Department of Pathophysiology and Transplantation, Milano, Italy; 2Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, and Fondazione Luigi Villa, Milano, Italy; 3Biological Resource Center and Department of Transfusion Medicine, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano, Italy
64PDF: 26 -
CO058 | ELEVATED PLASMA LEVELS OF OMEGA-3 STEARIDONIC ACID ARE ASSOCIATED WITH DECREASED FACTOR VIII COAGULANT ACTIVITY INDEPENDENTLY OF FACTOR VIII ANTIGEN AND VON WILLEBRAND FACTOR LEVELS: PRELIMINARY RESULTS FROM AN ANGIOGRAPHICALLY-CONTROLLED CARDIOVASCULAR COHORT STUDY N. Osti1, G. Musuraca1, A. Castagna2, M. Spizzo2, P. Pattini2, G. Mango2, M. Baroni3, B. Lunghi3, G. Poli4, C. Brocco1, C. Angheben1, M. Grusse5, P. Van Dreden5, A. Anesi1, G. Lippi3, M. Del Greco1, S. Friso2, A. Ferro1, F. Bernardi3, N. Martinelli2 | 1Azienda Sanitaria Universitaria Integrata del Trentino, Trento, Italy; 2Dip. di Medicina, Università di Verona, Verona, Italy; 3Dip. di Scienze della Vita e Biotecnologie, Università di Ferrara, Ferrara, Italy; 4Sez. di Biochimica Clinica, Università di Verona, Verona, Italy; 5Clinical Research, Diagnostica STAGO, Gennevillers, France
57PDF: 24 -
PO019 | LONGITUDINAL COAGULATION PROFILING BY THROMBIN GENERATION AND CIRCULATING MICROVESISCLES OF INDIVIDUALS UNDERGOING GENDER-AFFIRMING HORMONE THERAPY E. Campello, A. Scala, A. Napolitano, C. Simion, C. Bulato, S. Toffanin, S. Gavasso, B. Serena, A. Montagna, A. Garolla, P. Simioni | Department of Medicine, University of Padova, Italy
52PDF: 27 -
CO068 | FACTORS AFFECTING SPONTANEOUS PLATELET AGGREGATION IN HEALTHY SUBJECTS AND PATIENTS WITH STABLE CORONARY ARTERY DISEASE M. Scavone1, A. Fioretti1, C. Ghali1, B. Clerici1, E. Popov2, G.M. Podda1, M. Cattaneo3 | 1Laboratorio di emostasi e trombosi, Dipartimento di Scienze della Salute, Università degli Studi di Milano, Divisione di Medicina Generale II, ASST Santi Paolo e Carlo, Italy; 2National Medical Research Center of Cardiology, Ministry of Health of the Russian Federation, Moscow, Russia; 3Fondazione Arianna Anticoagulazione, Bologna, Italy
79PDF: 27 -
CO018 | THE MOLI-SANI RISK SCORE, A MEASURE OF MODIFIABLE CARDIOVASCULAR RISK, PREDICTS NON-CARDIOVASCULAR MORTALITY AND SELECTED CANCERS, BUT NOT NEURODEGENERATIVE DISEASES F. Bracone1, S. Costanzo1|2, M. Bonaccio1, T. Panzera1, A. De Curtis1, S. Magnacca1, C. Cerletti1, MB. Donati1, G. de Gaetano1, L. Iacoviello1|3, A. Di Castelnuovo1 | 1Unità di Ricerca di Epidemiologia e Prevenzione, IRCCS Neuromed, Pozzilli, Italy; 2Università della Insubria, Varese, Italy; 3Università LUM Giuseppe Degennaro, Casamassima, Italy
93PDF: 22 -
CO106 | ENDOTHELIAL DYSFUNCTION AS A POSSIBLE ADDITIONAL DRIVER OF BLEEDING IN HERMANSKY–PUDLAK SYNDROME F. Tondi1, G. Purgatorio1, E. Giglio1, E. Petito1, E. Falcinelli1, G. Guglielmini1, P. Gresele1, C. Olgasi2, L. Bury1 | 1Dep. of Medicine and Surgery, Section of Internal and Cardiovascular Medicine, University of Perugia, Perugia, Italy; 2Dep. of Translational Medicine, School of Medicine, University of Piemonte Orientale, Novara, Italy
62PDF: 20 -
CO050 | INTERACTION BETWEEN DIRECT ORAL ANTICOAGULANTS AND ANTIEPILEPTIC DRUGS: A MULTICENTER OBSERVATIONAL STUDY A. Lipari1, S. Sorrentino1, M. De Siati1, L. D'Innocenzo1, A. Ferretti1, D. Menichelli2, V. Cammisotto2, P. Pignatelli2, G. Ragna3, MC. Vedovati3, C. Becattini3, G. Frisullo4, V. Forte5, T. Pirozzi1, L. Di Gennaro1, M. Basso1, E. De Candia1 | 1Unit of Haemostasis and Thrombosis Diseases, Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italy; 2Department of Clinical Internal, Anesthesiological and Cardiovascular Sciences, Sapienza University of Roma, Roma, Italy; 3Department of Internal and Cardiovascular Medicine and Stroke Unit, University of Perugia, Perugia, Italy; 4Dipartimento di Neuroscienze, Organi di Senso e Torace, Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italy; 5Hematology, Department of Biomedicine and Prevention, University of Rome Tor Vergata, Roma, Italy
68PDF: 29 -
CO20 | Coagulation alterations as prognostic indicators in septic patients L. Baratti1, S. N. Pasturenzi1, P. Onorato2, W. Ageno3, F. Cortellaro2, M.P. Donadini2,4 | 1Scuola di Medicina, Università degli Studi dell’Insubria, Varese; 2Pronto Soccorso e Medicina d’Urgenza, Ospedale di Circolo, Varese; 3Dipartimento di Medicina, Università degli Studi di Padova; 4Dipartimento di Medicina e Chirurgia, Università degli Studi dell’Insubria, Varese, Italy
656PDF: 25 -
PO010 | D-DIMER TESTING BEYOND THROMBOSIS: A LABORATORY AUDIT OF TEST UTILIZATION, APPROPRIATENESS AND INTERPRETIVE CHALLENGES A. Mameli1, E. Casula2, E. Poma2, F. Marongiu1, D. Barcellona1 | 1Haemostasis and Thrombosis Unit; 2Laboratory Clinical Chemical Analysis and Microbiology, Azienda Ospedaliero-Universitaria (A.O.U.), Cagliari, Italy
63PDF: 22 -
PO43 | ELEVATED CIRCULATING TISSUE PLASMINOGEN ACTIVATOR LEVELS PREDICT GASTROINTESTINAL AND BREAST CANCER RISK: A PROSPECTIVE NESTED CASE-COHORT STUDY S. Bolognini1|2, C. Ticozzi1, P. Gomez-Rosas1|3, F. Schieppati1|2, G. Sampietro4, L. Barcella1, M. Marchetti1|2, A. Falanga1|2 | 1Immunohematology and Transfusion Medicine, Hospital Papa Giovanni XXIII, Bergamo, Italy; 2School of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy; 3Maastricht University Medical Center, Cardiovascular Research Institute Maastricht (CARIM), Maastricht, The Netherlands; 4Unit of Epidemiology and Statistics, ATS Bergamo, Italy
483PDF: 116 -
PO059 | HYPERCOAGULABILITY AND THROMBOTIC RISK IN MODERATE-TO-SEVERE OBSTRUCTIVE SLEEP APNEA: A PROSPECTIVE OBSERVATIONAL STUDY L. Spiezia1, S. Carraro2, E. Bicego1, A. Napolitano1, C. Samà1, A. Benetti1, B. Serena1, R. Marchese Ragona2, P. Simioni1 | 1Dipartimento di Medicina, Azienda Osp. Università di Padova, Italy; 2Dipartimento di Neuroscienze, Azienda Osp. Università di Padova, Italy
46PDF: 31 -
CO009 | EVALUATION OF A NON-LABORATORY CARDIOVASCULAR RISK SCORE ADAPTED FOR RURAL TANZANIA F. Mazzinghi1, B.S. Kakala1, J.J. Thomas1, R.J. Itambu1, B. Ndunguru1, S. Marwa1, B. Mfaume1, A. Mele1, M. Tilli1, E. Mwumbe1, P. Belardi1, G. Torelli2, M. Saugo3, P. Bartolotta3, V. Scheggi4, R. Marcucci5 | 1Doctors with Africa CUAMM, Iringa, Tanzania; 2Doctors with Africa CUAMM, Padova, Italy; 3Department of clinical and evaluative epidemiology, Trento Health Service, Trento, Italy; 4Cardiovascular Medicine, Careggi University Hospital, Firenze, Italy; 5Department of clinical and experimental medicine, University of Florence, Firenze, Italy
139PDF: 30 -
PO140 | HISTORY OF FALLS IN PATIENTS WITH ATRIAL FIBRILLATION: A SYSTEMATIC REVIEW AND META-ANALYSIS A.P. Speziale1, G. Buoninfante1, A. Ronca2|4, B. Corica3, V. Trapani1, M. Moretti1, G. Annecchini1, R. Cangemi1, V. Raparelli1, M. Proietti2|4, S. Basili1, G.F. Romiti5 | 1Department of Translational and Precision Medicine, Sapienza University of Roma, Roma, Italy; 2Department of Clinical Sciences and Community Health, University of Milano, Milano, Italy; 3University of Modena and Reggio Emilia, Modena, Italy; 4Division of Subacute Care, IRCCS Istituti Clinici Scientifici Maugeri, Milano, Italy; 5Department of Wellbeing, Health and Environmental Sustainability, Sapienza University of Roma, Rieti, Italy
43PDF: 22 -
PO38 | PERICATHETER AND SYSTEMIC THROMBOSIS DURING CAR-T LYMPHOCYTAPHERESIS: INCIDENCE AND CLINICAL CORRELATES I. Pansini1|2, E. Galli1, A. Corrente2, N. Piccirillo1|2, M. Viscovo1|2, S. Hohaus1|2, P. Chiusolo1|2, F. Sorà1|2, S. Sica1|2 | 1Department of Laboratory and Hematologic Sciences, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome; 2Hematology Section, Department of Radiologic and Hematologic Sciences, Università Cattolica del Sacro Cuore, Rome, Italy
454PDF: 103 -
CO066 | COAGULOPATHY IN CAR-T CELL-TREATED PATIENTS WITH LYMPHOPROLIFERATIVE DISORDERS: A RETROSPECTIVE, SINGLE-CENTER OBSERVATIONAL STUDY I. Santo1, R. Morganti2, G. Leoni3, G. Tancredi3, L. Contino4, S. Galimberti3, R.M. Santi4, E. Orciuolo5 | 1Azienda Toscana Nord Ovest, Versilia Hospital, Italy; 2Hematology Division AOUP, Pisa, Italy; 3University of Pisa, Hematology Pisa, Italy; 4Azienda Ospedaliera Universitaria Alessandria, Italy; 5Azienda Ospedaliera Universitaria Pisana, Hematology Pisa, Italy
61PDF: 31 -
PO36 | Venous stenting for symptomatic iliac thrombosis: five-years experience of single center I. Nichele1, G. Marchesini1, L. Boi2, G. Carli1, A. Tosetto1 | 1Hemophilia and Thrombosis Center, Hematology Department, S. Bortolo Hospital, Vicenza; 2Radiology Department, Ospedale Ca’ Foncello, Treviso, Italy
642PDF: 33 -
PO055 | THROMBIN GENERATION PROFILES IN PATIENTS WITH WILD-TYPE TRANSTHYRETIN AMYLOIDOSIS L. Spiezia1, A. Napolitano1, C. Bulato1, S. Toffanin1, A. Benetti1, C. Samà1, L. De Michieli2, G. Sinigiani2, A. Cipriani2, P. Simioni1 | 1Dipartimento di Medicina, Azienda Osp. Università di Padova, Italy; 2Dipartimento di Scienze cardio toraco vascolari, Azienda Osp. Università di Padova, Italy
47PDF: 26 -
CO101 | PLATELET ACTIVATION AND THROMBOGENICITY IN ANTI-PHOSPHOLIPID ANTIBODY-POSITIVE SUBJECTS: AN INTEGRATED TGA AND T-TAS ANALYSIS G. Rosati1, A. Pozzi1, C. Barale1, M. Padrini1, R.M. Medici1, G. Ferrari1, E. Mordohovich1, M. Tamietti1, A. Barinotti2, M. Radin2, M. Geminiani1, M. De Gobbi1, I. Russo1, A. Morotti1 | 1Dip. Scienze Cliniche e Biologiche, Torino, Italy; 2Osp. San Giovanni Bosco, Torino, Italy
80PDF: 27 -
CO024 | THE ROLE OF BLOOD CLOTTING AND ENDOTHELIAL ACTIVATION IN THE STRATIFICATION OF BLEEDING AND THROMBOTIC RISK OF ATRIAL FIBRILLATION ON ORAL ANTICOAGULANT THERAPY: INSIGHTS FROM THE STRAT-AF 2 STUDY F. Alfano1|2, AM. Gori1|2, A. Bertelli1, G. Ciarrocca Taranta1, M. Di Gioia2, F. Cesari1, A. Rogolino1, A. Sorrentino1, B. Giusti1|2, R. Marcucci1|2 | 1Department of Experimental and Clinical Medicine, University of Florence, Firenze, Italy; 2Center for Atherothrombotic Diseases, Careggi University Hospital, Firenze, Italy
55PDF: 30 -
CO16 | The predictive value of high-sensitivity C-reactive protein for assessing thrombosis risk in non-small cell lung cancer P. Gomez-Rosas1,2, M. Marchetti1,3, L. Russo1, C.J. Tartari1, S. Bolognini1, C. Ticozzi1, F. Schieppati1, A. D’Alessio4, R. Labianca5, A. Falanga1,3 All on behalf of the Hypercan Investigators | 1Hospital Papa Giovanni XXIII, Bergamo, Italy; 2Cardiovascular Research Institute Maastricht, CARIM, Maastricht University, Maastricht, the Netherlands; 3School of Medicine and Surgery, University of Milan Bicocca, Italy; 4University Vita-Salute San Raffaele, Milan, Italy; 5Fondazione ARTET Onlus, Bergamo, Italy
648PDF: 25 -
PO17 | PREDICTIVE VALUE OF INFLAMMATORY AND ENDOTHELIAL BIOMARKERS FOR CANCER RISK IN HEALTHY INDIVIDUALS: EVIDENCE FROM THE HYPERCAN STUDY C. Ticozzi1, S. Bolognini1|2, P. Gomez-Rosas1|3, F. Schieppati1|2, G. Sampietro4, L. Barcella1, M. Marchetti1|2, A. Falanga1|2 | 1Immunohematology and Transfusion Medicine, Hospital Papa Giovanni XXIII, Bergamo, Italy; 2School of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy; 3Maastricht University Medical Center, Cardiovascular Research Institute Maastricht (CARIM), Maastricht, The Netherlands; 4Unit of Epidemiology and Statistics, ATS Bergamo, Italy
457PDF: 103 -
CO062 | REDUCED-DOSE DOACs IN EXTENDED TREATMENT OF CANCER-ASSOCIATED THROMBOSIS (RED-CAT): INTERIM ANALYSIS FROM A MULTICENTER RETROSPECTIVE OBSERVATIONAL STUDY (COORDINATING CENTER DATA) S. Bergonzi1|2|3, A. Ghigo4, L. Carpisassi4, G. Murante1|2|3, M. Capetta1|2|3, F. Valeri1|2, C. Dainese1|2, A. Valpreda3|5, R. Pastorino3|5, F. Bocchi3|5, A. Porreca6|7, B. Bruno2|3, A. Borchiellini1|2 | 1Regional Centre for Hemorrhagic and Thrombotic Diseases, AOU Città della Salute e della Scienza, Turin, Italy; 2Division of Hematology, AOU Città della Salute e della Scienza, Università di Torino, Italy; 3Department of Molecular Biotechnology and Health Sciences, University of Turin, Italy; 4Division of Internal Medicine, AOU Città della Salute e della Scienza, Università di Torino, Italy; 5Central Laboratory Baldi and Riberi, AOU Città della Salute e della Scienza, Università di Torino, Italy; 6Department of Human Sciences and Quality of Life Promotion, San Raffaele University, Roma, Italy; 7Clinical and Molecular Epidemiology, IRCCS San Raffaele, Roma, Italy
52PDF: 31 -
PO35 | Cerebral veins thrombosis in patients with and without myeloproliferative neoplasm: a real life retrospective monocentric study I. Bertozzi, M.T. Sartori, M. Zerbinati, G. Libralon, A. Galbiati, P. Simioni | First Medical Clinic, Department of Medicine - DIMED, Università degli Studi di Padova, Italy
613PDF: 36 -
PO051 | ENDOGENOUS THROMBIN POTENTIAL RATIO AS A PREDICTOR OF BIRTHWEIGHT PERCENTILE IN PREGNANCY G. Tiscia1, F. Cappucci1, A. de Laurenzo1, M.P. Palumbo1, D. Colaizzo1, E. Grandone1|2 | 1IRCCS Casa Sollievo della Sofferenza, Italy; 2Università degli Studi di Foggia, Italy
76PDF: 26 -
CO087 | PLATELET ACTIVATION AND THROMBOSIS IN PATIENTS WITH FACTOR V LEIDEN MUTATION: A CROSS-SECTIONAL STUDY V. Cammisotto1, E. Valeriani2, S. Bartimoccia1, V. Castellani1, A. Pannunzio3, I. Palumbo3, C. Nocella1, R. Carnevale4, F. Violi1, P. Pignatelli1 | 1Department of Medical and Cardiovascular Sciences, Sapienza University of Roma, Italy; 2Department of Infectious Disease, AOU Policlinico Umberto I, Roma, Italy; 3Department of General Surgery and Surgical Speciality, Sapienza University of Roma, Italy; 4Department of Medical-Surgical Sciences and Biotechnologies, Sapienza University of Roma, Italy
56PDF: 26 -
PO110 | CLINICAL OUTCOMES AND SURVIVAL OF UNUSUAL SITE VENOUS THROMBOSIS IN PATIENTS WITH AND WITHOUT MYELOPROLIFERATIVE NEOPLASMS: A RETROSPECTIVE SINGLE-CENTER STUDY I. Bertozzi, M.T. Sartori, G. Libralon, M. Zerbinati, A. Galbiati, P. Simioni | Department of Medicine, University of Padova, Italy
53PDF: 28 -
CO114 | ANTI-PS/PT IgM IDENTIFIES AN ANTIGEN-DEFINED SUBSET WITHIN LUPUS ANTICOAGULANT POSITIVITY ASSOCIATED WITH THROMBOTIC PHENOTYPE M. Sacco1, S. Lancellotti1, A. Ferretti1, M. Basso1, C. Gavotti2, A. Ortolan2, V.A. Pacucci2, P. Calzoni3, L. Puccetti3, R. De Cristofaro1|4 | 1Center for Hemorrhagic and Thrombotic Diseases; 2Rheumatology and Clinical Immunology Unit, Fondazione Policl. Univ. Gemelli IRCCS, Roma, Italy; 3Azienda Ospedaliera-Universitaria Senese, Unità specialistica Coagulopatie Trombotiche ed Emorragiche, Dipartimento di Scienze Mediche, Chirurgiche e Neuroscienze, Università di Siena, Siena, Italy; 4Department of Translational Medicine and Surgery, Catholic University of the Sacred Heart, Roma, Italy
62PDF: 22 -
PO14 | SYMPTOM BURDEN IN PATIENTS WITH CANCER AND THROMBOEMBOLISM: A POPULATION-BASED MATCHED COHORT STUDY D. Siegal1|2, Z. O’Neill1|2, L. Nguyen3, N. Liu3, M. Carrier1|2, R. Sutradhar3|4 | 1Ottawa Hospital Research Institute, Ottawa; 2Department of Medicine, University of Ottawa, Ottawa; 3ICES, Toronto, Canada; 4Dalla Lana School of Public Health, University of Toronto, Toronto, Canada
511PDF: 112 -
CO061 | IMMUNOFLUORESCENCE MICROSCOPY REVEALS PLATELET- AND RED BLOOD CELL ALTERATIONS AS MORPHOLOGICAL BIOMARKERS IN MYELOPROLIFERATIVE NEOPLASMS C. Zaninetti1, L. Kaderali2, L. Vater1, S. Semenowitsch1, L. Porges1, T.M. Schnöder3|4, C.C. Crodel5, J. Fuhrmann1, J. Wesche1, C. Freyer1, T. Thiele1, F.H. Heidel3|6, A. Greinacher1 | 1Institut für Transfusionsmedizin Universitätsmedizin Greifswald, Greifswald, Germany; 2Institut für Bioinformatik, Universitätsmedizin Greifswald, Greifswald, Germany; 3Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany; 4Innere Medizin C, Universitätsmedizin Greifswald, Greifswald, Germany; 5Innere Medizin II, Abt. Hämatologie und Onkologie, Universitätsklinikum Jena, Jena, Germany; 6Leibniz Institute on Aging, Fritz-Lipmann Institute, Jena, Germany
50PDF: 23 -
PO33 | Whole blood hypercoagulable profiles in patients with rheumatoid arthritis L. Spiezia1, A. Giollo2, C. Samà1, A. Benetti1, L. Di Luozzo2, M. Salvato2, A. Doria2, P. Simioni1 | 1First Chair of Internal Medicine, Thrombotic and Hemorrhagic Diseases Unit, Department of Medicine, University Hospital of Padova; 2Rheumatology Unit, Department of Medicine, University Hospital of Padova, Italy
643PDF: 22 -
PO030 | PLATELET AGGREGOMETRY AS POTENTIAL TOOL TO EVALUATE ANTI-PLATELET RESPONSE IN MYELOPROLIFERATIVE NEOPLASMS: COMPARISON OF DIFFERENT TECHNIQUES AND INITIAL RESULTS A. Galbiati, I. Bertozzi, C. Fortino, D. Regazzo, L. Gianesello, F. Sartorello, V. Azzaro, G. Saggiorato, A. Napolitano, L. Fabris, P. Simioni | Department of Medicine, University of Padova, Italy
45PDF: 32 -
Clinical characteristics, prescription patterns and clinical outcomes of patients with extended therapy with direct oral anticoagulants for unprovoked venous thromboembolism Insights from the RIETE Registry
1579PDF: 146SUPPLEMENTARY FILES: 104APPENDIX: 122 -
PO59 | Efficacy and safety of different anticoagulant treatment regimens for isolated internal jugular vein thrombosis: a case series A. Pannunzio1, E. Valeriani1, I.M. Palumbo1, S. Marucci2, D. Menichelli1, D. Pastori2, P. Pignatelli2 | 1Department of General Surgery and Surgical Specialty, Sapienza University of Roma; 2Department of Clinical, Internal Medicine, Anaesthesiological and Cardiovascular Sciences, Sapienza University of Roma, Italy
709PDF: 42 -
PO103 | THE EFFECT OF ALBUMIN ON SERUM CONCENTRATION OF DIRECT ORAL ANTICOAGULANTS: A CROSS-SECTIONAL STUDY A. Pannunzio1, E. Valeriani2, I.M. Palumbo1, V. Cammisotto3, S. Bartimoccia3, V. Castellani3, S. Marucci3, D. Pastori3, D. Menichelli3, P. Pignatelli3 | 1Dip. di Chirurgia generale, specialistica ed anestesiologia - Università degli studi di Roma La Sapienza, Italy; 2Dip. di Medicina Interna, Scienze Endocrino-metaboliche e Malattie Infettive - Università degli Studi di Roma La Sapienza, Italy; 3Dip. di Medicina e Scienze Cardiovascolari - Università degli Studi di Roma La Sapienza, Italy
46PDF: 23 -
CO022 | SUBOPTIMAL MEDITERRANEAN DIET ADHERENCE IN VASCULAR PREVENTION: BASELINE FINDINGS FROM THE NEUROMED CENTER OF THE CV-PREVITAL STUDY F. De Rita1, M. Bonaccio1, A. Di Castelnuovo1, S. Costanzo1|2, T. Panzera1, A. De Curtis1, S. Magnacca1, C. Cerletti1, M.B. Donati1, G. de Gaetano1, L. Iacoviello1|3, F. Bracone1 | 1Unità di Ricerca di Epidemiologia e Prevenzione, IRCCS Neuromed, Pozzilli, Italy; 2Università della Insubria, Varese, Italy; 3Università LUM Giuseppe Degennaro, Casamassima, Italy. On behalf of CV-PREVITAL Study Group
56PDF: 24 -
CO112 | LIPOPROTEIN(a) PLASMA LEVELS AND COAGULATION BIOMARKERS: RESULTS FROM A COMPREHENSIVE LABORATORY ASSESSMENT IN AN ANGIOGRAPHICALLY-CONTROLLED CARDIOVASCULAR COHORT N. Osti1, G. Musuraca1, M. Spizzo2, P. Pattini2, G. Poli3, C. Brocco1, C. Cemin1, A. Madaffari1, G. Mango2, F. Presa2, M. Grusse4, P. Van Dreden4, A. Anesi1, G. Lippi3, M. Del Greco1, A. Castagna2, S. Friso2, A. Ferro1, N. Martinelli2 | 1Azienda Sanitaria Universitaria Integrata del Trentino (ASUIT), Trento, Italy; 2U.O. Medicina Interna B, Dip. Medicina, Università di Verona, Italy; 3Sez. Biochimica Clinica, Università di Verona, Italy; 4Dep. Clinical Research, Diagnostica Stago, Gennevilliers, France
65PDF: 25 -
PO13 | OUTPATIENT TREATMENT OF VENOUS THROMBOEMBOLISM AND SUBSEQUENT RISK OF CANCER S. Sørensen, D. Farkas, H. Sørensen | Department of Clinical Epidemiology, Aarhus University Hospital and Aarhus University, Aarhus, Denmark
461PDF: 109 -
CO059 | EXTRACELLULAR VESICLES AS BIOMARKERS IN FAMILIAL HYPERCHOLESTEROLEMIAS TREATED WITH EVINACUMAB C. Samà1, A. Benetti1, M.G. Lupo2, M. Biolo1, C. Portinari1, S. Zambon1, A. Zambon1, N. Ferri2, C.M. Radu1, P. Simioni1 | 1First Chair of Internal Medicine and Thrombotic and Haemorrhagic Diseases Unit, Department of Medicine, Padova University Hospital, Padova, Italy; 2Department of Medicine, Padova University Hospital, Padova, Italy
54PDF: 26 -
PO023 | CLOPIDOGREL USE IN ANTIPLATELET MANAGEMENT OF ESSENTIAL THROMBOCYTHEMIA (TECLA STUDY): DESIGN AND FEASIBILITY OF A SINGLE-CENTRE STUDY P. Ranalli1|2, D. Bruno3, G. Petrucci4, M. D'Uva1|2, M. Di Marco5, P. Vitulli5, B. Rocca6, M. Di Ianni1|2 | 1Hematology Unit, S. Spirito Hospital, Pescara, Italy; 2Department of Medicine and Aging Sciences D’Annunzio University, Chieti, Italy; 3Hemostasis Laboratory, Transfusion Medicine Unit, S. Spirito Hospital, Pescara, Italy; 4Departmental Faculty of Medicine, Unicamillus, Rome, Italy; 5Cardiology Unit, S. Spirito Hospital, Pescara, Italy; 6Department of Medicine and Surgery, LUM University, Casamassima (BA), Italy
53PDF: 17 -
CO070 | PLASMIN GENERATION AND ITS INTERPLAY WITH COAGULATION AND FIBRINOLYSIS IN ATRIAL FIBRILLATION: IMPACT OF ANTICOAGULANT THERAPY G. Ciarrocca Taranta1, F. Alfano1, M. Di Gioia2, M. Berteotti1|2, E. Lotti2, F. Cesari2, A. Rogolino2, F.A. Barbuto1, A. M Gori1|2, E. Sticchi1|2, B. Giusti1|2, R. Marcucci1|2 | 1Dep of Experimental and Clinical Medicine, University of Florence, Italy; 2Atherothrombotic Diseases, Careggi University Hospital, Firenze, Italy
61PDF: 29 -
PO101 | COMPREHENSIVE EVALUATION OF COAGULATION PROFILES IN REFRACTORY MODERATE-TO-SEVERE ULCERATIVE COLITIS L. Spiezia1, G. Di Lecce2, B. Barberio2, M. Zanconato2, E. Bicego1, C. Samà1, B. Serena1, M. De Bona3, A. Buda3, F. Zingone2, E.V. Savarino2, P. Simioni1 | 1First Chair of Internal Medicine, Department of Medicine (DIMED), Padova University Hospital, Padova, Italy; 2Gastroenterology Unit, Department of Surgery, Oncology and Gastroenterology (DISCOG), University of Padova, Padova, Italy; 3Gastroenterology Unit, Department of Oncological Gastrointestinal Surgery, S. Maria del Prato Hospital, Feltre, Italy
49PDF: 30 -
CO021 | TIME COURSE OF LP(a) LEVELS AFTER ACUTE CORONARY SYNDROME: A LONGITUDINAL STUDY G. Barbieri1, A.M. Gori1, G. Ciarrocca Taranta1, M. Di Gioia1, F. Alfano1, E. Lotti1, A. Rogolino1, F. Cesari1, B. Giusti1, M. Berteotti1, R. Marcucci1 | 1Atherothrombotic Diseases Center, Department of Experimental and Clinical Medicine, University of Florence - Careggi Hospital, Firenze, Italy
60PDF: 24 -
PO09 | CANCER MORTALITY AFTER INCIDENT VENOUS THROMBOEMBOLISM C. Langholm1, N.H. Eide1, K. Hveem2|3|4, N. Van Es5|6, V.M. Morelli1|7, S.K. Braekkan1|7, J.B. Hansen1|7 | 1Thrombosis Research Group, Department of Clinical Medicine, UiT – The Arctic University of Norway, Tromsø, Norway; 2HUNT Research Centre, Department of Public Health and General Practice, Norwegian University of Science and Technology, Levanger, Norway; 3HUNT Center for Molecular and Clinical Epidemiology, Department of Public Health and Nursing, Norwegian University of Science and Technology, Trondheim, Norway; 4Department of Research, St. Olav University Hospital, Trondheim, Norway; 5Department of Vascular Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands; 6Amsterdam Cardiovascular Sciences Pulmonary Hypertension and Thrombosis Amsterdam, the Netherlands; 7Thrombosis Research Center, Department of Internal Medicine, University Hospital of North Norway, Tromsø, Norway
487PDF: 100
1 - 73 of 73 items
